Today, more than 30, people in the United States are living with cystic fibrosis CF — a hereditary condition characterized by thick, sticky mucus that clogs airways and traps germs, leading to infections, inflammation and other complications. A new combination drug, FDA approved in October , provides relief for patients with the most common CF gene mutation F del — estimated to represent 90 percent of individuals living with the disease.
Infection with the hepatitis C virus can lead to serious, life-threatening health problems like liver failure, cirrhosis and liver cancer. With no vaccine for the virus, patients have been limited to medication, but many treatments were accompanied by adverse side effects or only effective for certain genotypes of the disease. A new, approved fixed-dose combination medication has vastly improved hepatitis C treatment. More than 90 percent effective for hepatitis C genotypes one through six, the therapy represents an effective option for a wider scope of patients.
Underweight and frail, babies born prematurely often require specialized care — including ventilation for those with infant respiratory distress syndrome IRDS. For IRDS, infants are commonly administered surfactant during mechanical ventilation, a practice that can cause lasting lung injury in preterm infants and contribute to the development of chronic lung disease.
Unlike mechanical ventilation, b-CPAP is a non-invasive ventilation strategy — delivering continuous positive airway pressure to newborns to maintain lung volumes during exhalation.
The oscillating, rather than constant pressure, plays a role in its safety and efficacy, minimizing physical trauma and stimulating lung growth when administered over a prolonged period.
COVID saw increased adoption of telemedical practices as clinicians needed to conduct patient visits online. An increasingly virtual care model and increased consumer adoption came by way of fundamental shifts in policy at both the government and provider level.
Since March, state and federal regulators have moved quickly to reduce barriers to telehealth, understanding that these new tools can speed access to care while protecting healthcare workers and community members. These measures opened the floodgates for telehealth, allowing for new programs and the expansion of existing networks. Characterized as excessive bleeding after having a baby, postpartum hemorrhage is a devastating complication of childbirth, affecting from one to five percent of women who give birth.
Mothers experiencing postpartum hemorrhage may require blood transfusions, drugs which may cause dangerous side effects, long uncomfortable procedures, and even emergency hysterectomy with loss of fertility.
Non-surgical interventions directed at the site of bleeding has been limited to balloon devices that expand the uterus while compressing the site of bleeding. But the newest advancement is that of vacuum-induced uterine tamponade — a method that uses negative pressure created inside the uterus to collapse the bleeding cavity causing the muscle to close off the vessels.
The vacuum-induced device represents another minimally invasive tool for clinicians as they treat the complication and provides a low-tech solution that is potentially translatable to developing countries with low resource availability. Hearing devices are in the midst of a huge change to their delivery model. Discover how innovation and teamwork transformed the life of a young gunshot wound survivor.
Here is a behind-the-scenes look at the third face transplant performed at Cleveland Clinic. Cleveland Clinic is a non-profit academic medical center.
Advertising on our site helps support our mission. The Center has a diverse portfolio of technology development projects available for partnering or licensing. We provide education tools and resources for biomedical and life sciences technology commercialization.
Skip Main Navigation Significantly increasing the generation of new, patient-benefiting products.
0コメント